HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Masamichi Sugimoto Selected Research
Masamichi Sugimoto Research Topics
Disease
15
Neoplasms (Cancer)
11/2023 - 12/2008
5
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
12/2021 - 02/2015
3
Hepatocellular Carcinoma (Hepatoma)
11/2010 - 01/2009
2
Brain Neoplasms (Brain Tumor)
01/2022 - 01/2020
2
Neoplasm Metastasis (Metastasis)
01/2022 - 01/2020
2
Disease Progression
09/2019 - 01/2017
2
Liver Neoplasms (Liver Cancer)
05/2009 - 12/2008
2
Lymphoma (Lymphomas)
12/2004 - 11/2002
1
Adenocarcinoma of Lung
01/2023
1
Breast Neoplasms (Breast Cancer)
09/2022
1
Pneumonia (Pneumonitis)
12/2021
1
Ovarian Neoplasms (Ovarian Cancer)
09/2019
1
Carcinoma (Carcinomatosis)
09/2019
1
Multiple Myeloma
10/2010
1
Leukemia
12/2004
1
Rheumatoid Arthritis
06/2003
1
Acquired Immunodeficiency Syndrome (AIDS)
11/2002
Drug/Important Bio-Agent (IBA)
6
Bevacizumab (Avastin)
FDA Link
09/2022 - 01/2017
5
Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)
IBA
01/2023 - 06/2003
5
Antibodies
IBA
02/2022 - 01/2009
4
Glypicans
IBA
11/2010 - 12/2008
3
B7-H1 Antigen
IBA
11/2023 - 01/2022
3
Immune Checkpoint Inhibitors
IBA
01/2023 - 01/2021
3
codrituzumab
IBA
11/2010 - 12/2008
2
Therapeutic Uses
IBA
11/2023 - 04/2019
2
Chemokines
IBA
02/2022 - 04/2019
2
Ligands
IBA
02/2022 - 01/2021
2
Immunoglobulin G (IgG)
IBA
01/2022 - 01/2020
2
Paclitaxel (Taxol)
FDA Link
Generic
09/2019 - 01/2017
2
Erlotinib Hydrochloride (CP 358,774)
FDA Link
08/2017 - 02/2015
2
ErbB Receptors (EGF Receptor)
IBA
08/2017 - 02/2015
2
Tyrosine Kinase Inhibitors
IBA
08/2017 - 02/2015
2
Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)
IBA
11/2010 - 01/2009
2
Monoclonal Antibodies
IBA
11/2010 - 10/2010
2
Interleukin-6 (Interleukin 6)
IBA
06/2003 - 11/2002
1
naringin
IBA
11/2023
1
RNA (Ribonucleic Acid)
IBA
01/2023
1
Indicators and Reagents (Reagents)
IBA
01/2023
1
Transforming Growth Factors (Transforming Growth Factor)
IBA
01/2023
1
palbociclib
IBA
09/2022
1
Hormones (Hormone)
IBA
09/2022
1
Growth Factor Receptors
IBA
09/2022
1
atezolizumab
IBA
12/2021
1
Angiogenesis Inhibitors
IBA
01/2021
1
liposomal doxorubicin (Doxil)
FDA Link
09/2019
1
Insulin-Like Peptides
IBA
09/2019
1
Cisplatin (Platino)
FDA Link
Generic
04/2019
1
Immune Checkpoint Proteins
IBA
04/2019
1
Irinotecan (Camptosar)
FDA Link
Generic
07/2018
1
Folic Acid (Vitamin M)
FDA Link
Generic
07/2018
1
onartuzumab
IBA
02/2015
1
Glycosylphosphatidylinositols (Glycosyl-Phosphatidylinositol)
IBA
11/2010
1
Bone Marrow Stromal Antigen 2
IBA
10/2010
1
Carbohydrates
IBA
12/2008
1
Antineoplastic Agents (Antineoplastics)
IBA
12/2008
1
Mitogens
IBA
12/2004
Therapy/Procedure
8
Therapeutics
11/2023 - 06/2003
3
Immunotherapy
11/2023 - 01/2021
3
Drug Therapy (Chemotherapy)
09/2022 - 09/2019
1
Aftercare (After-Treatment)
09/2022
1
Combination Drug Therapy (Combination Chemotherapy)
01/2017